Serum Albumin < 2.5 g/dL
Serum albumin >= 2.8 g/dL
Albumin >= 3 g/dL, within 14 days of registration and within 7 days of the start of treatment
Serum albumin >= 2.8 g/dL
Serum albumin >= 28 g/L
Serum albumin >= 2.5 g/dL
Patients must have a serum albumin >= 2.5 g/dL within 28 days prior to registration
Albumin >= 2.5 g/dL
Serum albumin >= 2 g/dL
Albumin >= 2.5 g/dL
Albumin >= 2.5 g/dL
Serum albumin >= 2 g/dL
Albumin >= 2.5 g/dL
Serum albumin >= 3 g/dL
Patients on Part A and Part B: serum albumin >= 2 g/dL
Patients on Part C with ALL: serum albumin >= 2 g/dL
Albumin >= 2.5 mg/dl
Albumin >= 2.5 g/dL
Serum albumin >= 2.5 g/dL
Serum albumin >= 2.8 g/dL
Albumin >= 2.5 g/dL
Serum albumin >= 2.8 g/dL
Serum albumin >= 2 g/dL
Albumin >= 2.8 g/dL
Albumin >= 2 g/dl
INCLUSION CRITERIA FOR STRATUM C: Albumin >= 2 g/dl
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 3 g/dL
Within 14 days prior to registration: Serum albumin >= 3.0 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dl
Albumin >= 2 g/dl
Serum albumin >= 2.8 g/dL
Serum albumin >= 2 g/dL
Patients with hypersensitivity to albumin are not eligible
Albumin >= 2.5 g/dL within 28 days prior to registration
Albumin >= 2.5 g/dl
Albumin >= 2.5 g/dL within 30 days of day 1 of study
Patients with solid tumors: serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL
Serum albumin >= 2 g/dL within 7 days prior to enrollment
